234 filings
Page 5 of 12
8-K
dsw6hxs1aak n5
29 Oct 20
Other Events
5:28pm
424B5
e48erecudqyijvg9v
29 Oct 20
Prospectus supplement for primary offering
5:25pm
424B5
igfwm pn98m
28 Oct 20
Prospectus supplement for primary offering
5:29pm
424B5
be4 rek62e2ggcc2ma
28 Oct 20
Prospectus supplement for primary offering
4:32pm
8-K
nb44qfb
9 Sep 20
Forte Biosciences, Inc. Announces Full Publication of Phase 1/2 Data In Science Translational Medicine
4:06pm
424B5
7dfqi tl5sydu85
4 Sep 20
Prospectus supplement for primary offering
4:51pm
8-K
c8xeli5og3v20
4 Sep 20
Audited Financial Statements
4:31pm
S-8
g3fkljpyjhgzwa1
11 Aug 20
Registration of securities for employees
5:19pm
8-K
c0oi7wo7i d6logt2m
10 Aug 20
Forte Biosciences, Inc. Announces Second Quarter 2020 Results and Provides General Business Update
4:04pm
8-K/A
u3uxom0aln6n2hvion
10 Aug 20
Financial Statements and Exhibits
4:02pm
8-K
89wywcba cqkix
21 Jul 20
Changes in Registrant's Certifying Accountant
4:34pm
8-K
7vjqq cbx9
26 Jun 20
Regulation FD Disclosure
5:09pm
8-K
xyoyhd76nat dmd
15 Jun 20
Forte Biosciences, Inc. Announces Closing of Merger with Tocagen
5:21pm
8-K
dfjv quxkpgf
12 Jun 20
Submission of Matters to a Vote of Security Holders
4:02pm
8-K
k6uda9s59mw1debzt6
8 Jun 20
Other Events
5:25pm
DEFA14A
j744xtojv7omtn1qn4
28 May 20
Additional proxy soliciting materials
4:57pm
EFFECT
4cqmool0nw33up2yjp
14 May 20
Notice of effectiveness
12:15am
424B3
hse2pyf
14 May 20
Prospectus supplement
12:00am